Timing-Dependent Autophagic Flux in Blood Cells as a Biomarker of Longevity Benefits from Active-Phase Caloric Restriction

Hypothesis

Active-phase caloric restriction (CR) enhances autophagic flux specifically in human circulating immune cells through a circadian‑regulated AMPK‑SIRT1‑FOXO3 axis, and this flux predicts improvements in biological aging pace (DunedinPACE) more accurately than systemic metabolic rate or body‑weight changes.

Rationale

CR robustly induces autophagy via mTOR inhibition, AMPK activation, and sirtuin upregulation across tissues [1]. In mice, aligning CR to the active circadian phase extends lifespan up to 35% independent of weight loss [4], suggesting that timing couples nutrient sensing to core clock machinery. Human studies show that 25% CR for two years slowed DunedinPACE by 2‑3%, translating to a 10‑15% mortality risk reduction [2]. Yet metabolic markers such as glucose or temperature poorly predict lifespan under CR, whereas genetic resilience—especially immune and erythrocyte health—does [3]. A newly validated assay enables direct measurement of autophagic flux in human blood cells [5], providing a tractable read‑out of the proposed mechanism.

We propose that the molecular link between timing and autophagy hinges on circadian control of NAD+ synthesis. During the active phase, NAD+ peaks, activating SIRT1, which deacetylates and activates AMPK and FOXO3, driving transcription of autophagy genes (LC3B, ATG5, BNIP3). Misaligned CR blunts this NAD+ surge, attenuating AMPK‑SIRT1‑FOXO3 signaling and thus autophagic flux, even if caloric intake is equally reduced.

Testable Predictions

1. Participants undergoing active‑phase CR (e.g., 20% calorie reduction consumed between 08:00‑18:00) will exhibit a significantly greater increase in autophagic flux in peripheral blood mononuclear cells after 4 weeks compared with those undergoing misaligned CR (same calorie reduction consumed between 20:00‑08:00), measured via the LC3‑II turnover assay [5].
2. The magnitude of flux increase will correlate negatively with change in DunedinPACE (r < ‑0.4, p < 0.01) and positively with improvements in immune‑cell phenotype markers (e.g., increased naïve‑to‑memory CD4+ ratio, reduced inflammasome activity).
3. Systemic metabolic rate (indirect calorimetry) and body‑weight change will show weak or non‑significant correlations with DunedinPACE shifts in the same cohort.

Experimental Design

• Cohort: 120 healthy adults aged 30‑50, randomized to three groups (n = 40 each): active‑phase CR, misaligned‑phase CR, and control (weight‑maintaining diet).
• Intervention: 20% calorie reduction for 12 weeks, with meals provided to ensure adherence; timing enforced via smartphone‑logged eating windows.
• Outcomes: Baseline and week‑12 measurements of (a) autophagic flux in isolated PBMCs using bafilomycin‑A1‑blocked LC3‑II Western blot (per protocol [5]), (b) DunedinPACE from epigenome‑wide methylation, (c) resting metabolic rate via indirect calorimetry, (d) body weight/composition, (e) immune‑cell flow cytometry panel.
• Analysis: Mixed‑effects models testing group × time interaction for autophagic flux; mediation analysis to assess whether flux change mediates the effect of CR timing on DunedinPACE.

Potential Confounds and Mitigations

Sleep duration and light exposure influence circadian phase; participants will wear actigraphy and maintain sleep logs, with statistical adjustment for variability. Nutrient composition will be iso‑caloric and matched across groups to isolate timing effects. Adherence will be verified by doubly‑labeled water for energy balance and meal‑timestamp compliance >90%.

If the hypotheses hold, autophagic flux in blood cells—readily obtained via a simple venipuncture—could serve as a dynamic, mechanistically grounded biomarker to personalize CR prescriptions, shifting focus from generic metabolic rate to circadian‑aligned cellular resilience.